The treatment of lung cancer depends on the tumour histology (e.g. small cell versus non-small cell, the disease stage [extent], estimated clinically and pathologically post-operatively, and patient specific factors such as age, pulmonary function, comorbidity and performance status).

When treating NSLC, systemic therapy is generally indicated for patients who present with advanced disease, including metastasis or recur following initial definitive treatment.

Please sign in to read more